A multicenter, open-label extension study to evaluate the long-term safety, tolerability, and efficacy of E2007 [perampanel] in patients with Parkinson's disease who experience end-of-dose 'wearing-off' motor fluctuations [EXTENSION OF 700010676]

Trial Profile

A multicenter, open-label extension study to evaluate the long-term safety, tolerability, and efficacy of E2007 [perampanel] in patients with Parkinson's disease who experience end-of-dose 'wearing-off' motor fluctuations [EXTENSION OF 700010676]

Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2009

At a glance

  • Drugs Perampanel (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Sponsors Eisai Inc
  • Most Recent Events

    • 10 Sep 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 01 Feb 2008 Status changed from recruiting to in progress.
    • 21 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top